Skip to Content

Differences and Similarities of the Four Approved JAK Inhibitors

In this MEDtalk, Dr. Roy Fleischmann discusses the differences and similarities between tofacitinib, baricitinib, upadacitinib, and filgotinib according to mode of action, efficacy, and safety.

Roy Fleischmann

Get access

If you are a doctor, nurse, or other health professionals, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top